PreprintCited by 2,411Antibiotic Use and ResistanceAntibiotic Resistance in BacteriaPharmaceutical and Antibiotic Environmental Impacts

Antimicrobial Resistance: A Growing Serious Threat for Global Public Health

Open access
Salam, Md. Abdus, Al-Amin, Md. Yusuf, Salam, Moushumi Tabassoom, Pawar, Jogendra, Akhter, Naseem, Rabaan, Ali A., Alqumber, Mohammed A. A.·2023·Healthcare

Preprint — published as 10.3390/healthcare11131946

Abstract

Antibiotics are the most magnificent discovery of 20th century that have saved millions of lives from infectious diseases. Microbes have developed acquired antimicrobial resistance (AMR) to many drugs due to high selection pressure from increasing use and misuse of antibiotics over the years. The transmission and acquisition of AMR occur primarily via human–human interface both within and outside of the healthcare facilities. A huge number of interdependent factors related to healthcare and agriculture govern the development of AMR through various drug resistance mechanisms. The emergence and spread of AMR from the unrestricted use of antimicrobials in livestock feed has been a major contributing factor. The prevalence of AMR bacteria has attained its incongruous level worldwide and threatening global public health as silent pandemic, necessitating urgent intervention. Therapeutic options of AMR bacterial infections are limited resulting in significant morbidity and mortality with high financial impact. The paucity in discovery and supply of new novel antimicrobials to treat life-threatening AMR infections stands in sharp contrast to demand. Immediate interventions to contain AMR include surveillance and monitoring, minimizing over the counter antibiotics and antibiotics in food animals, access to quality and affordable medicines, vaccines and diagnostics, and enforcement of legislation. An orchestral collaborative action within and between multiple national and international organizations are required urgently, otherwise, a post-antibiotic era can be a real possibility than an apocalyptic fantasy for the 21st century. This narrative review highlights on the basis, mechanisms and factors in microbial resistance and key strategies to combat antimicrobial resistance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.20944/preprints202305.0555.v1

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AMR limits the effectiveness of treatment options, leading to increased morbidity and treatment failure rates, longer hospital stays, elevated mortality rates, and higher healthcare costs.

    “AMR limits the effectiveness of treatment options, leading to increased morbidity and treatment failure rates, longer hospital stays, elevated mortality rates, and higher healthcare costs [2].”

    From A Systematic Review on Antimicrobial Resistance in Ghana from a One Health Perspective (2024) · cites this paper as [2]

    The Abstract (page unavailable) says microbes have acquired resistance to many drugs, supporting the claim that AMR limits treatment effectiveness. The available passages do not state that AMR increases morbidity, treatment failure, hospital stays, mortality, or healthcare costs; searches for those outcomes returned only references and other non-substantive text. (LLM, conf=0.72)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 43

  1. 2019) Journal of Microbiology, 57 (3), pp. 181-184. . doi: 10.1007/s12275-019-0718-8 · DOI
  2. Martinez, J.L. (2014) Drug Discovery Today: Technologies, 11 (1), pp. 33-39. . doi: 10.1016/j.ddtec.2014.02.001 · DOI
  3. Cox, G., Wright, G.D. (Open Access) (2013) International Journal of Medical Microbiology, 303 (6-7), pp. 287- 292. . doi: 10.1016/j.ijmm.2013.02.009 · DOI
  4. Holmes, A.H., Moore, L.S.P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., Guerin, P.J., (...), Piddock, L.J.V. (Open Access) (2016) The Lancet, 387 (10014), pp. 176-187. . doi: 10.1016/S0140-6736(15)00473-0 · DOI
  5. Munita, J.M., Arias, C.A. (Open Access) (2016) Microbiology Spectrum, 4 (2), art. no. VMBF-0016-2015. . doi: 10.1128/microbiolspec.VMBF-0016-2015 · DOI · Paper page
  6. Fernández, L., Hancock, R.E.W. (Open Access) (2012) Clinical Microbiology Reviews, 25 (4), pp. 661-681. . doi: 10.1128/CMR.00043-12 · DOI
  7. Godijk, N.G., Bootsma, M.C.J., Bonten, M.J.M. (Open Access) (2022) BMC Infectious Diseases, 22 (1), art. no. 482. . doi: 10.1186/s12879-022-07360-z · DOI
  8. Krzemiński, P., Markiewicz, Z., Popowska, M. Entry Routes of Antibiotics and Antimicrobial Resistance in the Environment (2020) Antibiotics and Antimicrobial Resistance Genes: Environmental Occurrence and Treatment Technologies, pp. 1-26. .
  9. Da Costa, P.M., Loureiro, L., Matos, A.J.F. (Open Access) (2013) International Journal of Environmental Research and Public Health, 10 (1), pp. 278-294. . doi: 10.3390/ijerph10010278 · DOI
  10. Landers, T.F., Cohen, B., Wittum, T.E., Larson, E.L. (2012) Public Health Reports, 127 (1), pp. 4-22. . doi: 10.1177/003335491212700103 · DOI
  11. Chancey, S.T., Zähner, D., Stephens, D.S. (Open Access) (2012) Future Microbiology, 7 (8), pp. 959-978. . doi: 10.2217/fmb.12.63 · DOI
  12. Reygaert, W.C. An overview of the antimicrobial resistance mechanisms of bacteria (2018) AIMS Microbiol, 4, pp. 482-501. . 31294229
  13. Choi, U., Lee, C.-R. (Open Access) (2019) Frontiers in Microbiology, 10 (APR), art. no. 953. . doi: 10.3389/fmicb.2019.00953 (2018) Infection and Drug Resistance, 11, pp. 523-530. . doi: 10.2147/IDR. · DOI
  14. Dutt, Y., Dhiman, R., Singh, T., Vibhuti, A., Gupta, A., Pandey, R.P., Raj, V.S., (...), Priyadarshini, A. (Open Access) (2022) Antibiotics, 11 (7), art. no. 930. . doi: 10.3390/antibiotics11070930 · DOI
  15. Van Acker, H., Van Dijck, P., Coenye, T. (Open Access) (2014) Trends in Microbiology, 22 (6), pp. 326-333. . doi: 10.1016/j.tim.2014.02.001 · DOI
  16. Ashley, R.E., Dittmore, A., McPherson, S.A., Turnbough, C.L., Neuman, K.C., Osheroff, N. (Open Access) (2017) Nucleic Acids Research, 45 (16), pp. 9611-9624. . doi: 10.1093/nar/gkx649 · DOI
  17. Saha, M., Sarkar, A. (Open Access) (2021) Journal of Xenobiotics, 11 (4), pp. 197-214. . doi: 10.3390/jox11040013 · DOI
  18. Foster, T.J. (2017) FEMS Microbiology Reviews, 41 (3), pp. 430-449. . doi: 10.1093/femsre/fux007 · DOI
  19. Wendlandt, S., Shen, J., Kadlec, K., Wang, Y., Li, B., Zhang, W.-J., Feßler, A.T., (...), Schwarz, S. (2015) Trends in Microbiology, 23 (1), pp. 44-54. . doi: 10.1016/j.tim.2014.10.002 · DOI
  20. Blair, J.M.A., Webber, M.A., Baylay, A.J., Ogbolu, D.O., Piddock, L.J.V. (2015) Nature Reviews Microbiology, 13 (1), pp. 42-51. . doi: 10.1038/nrmicro3380 · DOI · Paper page
  21. Nikaido, H., Pagès, J.-M. (Open Access) (2012) FEMS Microbiology Reviews, 36 (2), pp. 340-363. . doi: 10.1111/j.1574-6976.2011.00290.x · DOI
  22. Poole, K. (Open Access) (2005) Journal of Antimicrobial Chemotherapy, 56 (1), pp. 20-51. . doi: 10.1093/jac/dki171 · DOI · Paper page
  23. Blair, J.M.A., Richmond, G.E., Piddock, L.J.V. (Open Access) (2014) Future Microbiology, 9 (10), pp. 1165-1177. . doi: 10.2217/FMB.14.66 · DOI · Paper page
  24. Abushaheen, M.A., Muzaheed, Fatani, A.J., Alosaimi, M., Mansy, W., George, M., Acharya, S., (...), Jhugroo, P. (Open Access) (2020) Disease-a-Month, 66 (6), art. no. 100971. . doi: 10.1016/j.disamonth.2020.100971 (2018) Journal of Clinical Pharmacy and Therapeutics, 43 (5), pp. 606- 613. . doi: 10.1111/jcpt.12730 · DOI
  25. Chokshi, A., Sifri, Z., Cennimo, D., Horng, H. (Open Access) (2019) Journal of Global Infectious Diseases, 11 (1), pp. 36-42. . doi: 10.4103/jgid. · DOI
  26. Klein, E.Y., Van Boeckel, T.P., Martinez, E.M., Pant, S., Gandra, S., Levin, S.A., Goossens, H., (...), Laxminarayan, R. (Open Access) (2018) Proceedings of the National Academy of Sciences of the United States of America, 115 (15), pp. E3463-E3470. . doi: 10.1073/pnas.1717295115 · DOI · Paper page
  27. Van Boeckel, T.P., Brower, C., Gilbert, M., Grenfell, B.T., Levin, S.A., Robinson, T.P., Teillant, A., (...), Laxminarayan, R. (Open Access) (2015) Proceedings of the National Academy of Sciences of the United States of America, 112 (18), pp. 5649-5654. . doi: 10.1073/pnas.1503141112 Antibiotic Use in the United States, 2022 Update: Progress and Opportunities Available online · DOI
  28. Michael, C.A., Dominey-Howes, D., Labbate, M. (Open Access) (2014) Frontiers in Public Health, 2 (SEP), art. no. 145. . doi: 10.3389/fpubh.2014.00145 · DOI
  29. Pulia, M., Kern, M., Schwei, R.J., Shah, M.N., Sampene, E., Crnich, C.J. (2018) Antimicrobial Resistance and Infection Control, 7 (1), art. no. 74. . doi: 10.1186/s13756-018-0364-7 · DOI
  30. Woolhouse, M., Waugh, C., Perry, M.R., Nair, H. (Open Access) (2016) Journal of Global Health, 6 (1), art. no. 010306. . doi: 10.7189/jogh.06.010306 Antibiotic Resistance: A Global Threat. . Available online · DOI
  31. DiMasi, J.A., Grabowski, H.G., Hansen, R.W. (Open Access) (2016) Journal of Health Economics, 47, pp. 20-33. . doi: 10.1016/j.jhealeco.2016.01.012 · DOI · Paper page
  32. Chang, Q., Wang, W., Regev-Yochay, G., Lipsitch, M., Hanage, W.P. (2015) Evolutionary Applications, 8 (3), pp. 240-247. . doi: 10.1111/eva.12185 Animal production. . Available online · DOI
  33. Castro-Sánchez, E., Moore, L.S.P., Husson, F., Holmes, A.H. (Open Access) (2016) BMC Infectious Diseases, 16 (1), art. no. 465. . doi: 10.1186/s12879-016-1810-x (2019) Journal of Travel Medicine, 26 (8), art. no. taz036. . doi: 10.1093/jtm/taz036 · DOI
  34. Arcilla, M.S., van Hattem, J.M., Haverkate, M.R., Bootsma, M.C.J., van Genderen, P.J.J., Goorhuis, A., Grobusch, M.P., (...), Penders, J. (2017) The Lancet Infectious Diseases, 17 (1), pp. 78-85. . doi: 10.1016/S1473-3099(16)30319-X · DOI
  35. McCubbin, K.D., Anholt, R.M., de Jong, E., Ida, J.A., Nóbrega, D.B., Kastelic, J.P., Conly, J.M., (...), Barkema, H.W. (Open Access) (2021) Frontiers in Public Health, 9, art. no. 726484. . doi: 10.3389/fpubh.2021.726484 · DOI
  36. Carter, R.R., Sun, J., Jump, R.L.P. (Open Access) (2016) Open Forum Infectious Diseases, 3 (3). . doi: 10.1093/ofid/ofw112 Antibiotic resistance. . Available online · DOI
  37. Lin, T.Z., Jayasvasti, I., Tiraphat, S., Pengpid, S., Jayasvasti, M., Borriharn, P. (Open Access) (2022) Drug, Healthcare and Patient Safety, 14, pp. 27-36. doi: 10.2147/DHPS.S339808 Control, A. Global Governance to Tackle Antimicrobial Resistance: The Way Forward Available online http://resistancecontrol.info/2019-3/armed-conflicts-and-antimicrobial- resistance-a-deadly-convergence/ · DOI
  38. Majumder, M.A.A., Rahman, S., Cohall, D., Bharatha, A., Singh, K., Haque, M., Gittens-St Hilaire, M. (Open Access) (2020) Infection and Drug Resistance, 13, pp. 4713-4738. . doi: 10.2147/IDR.S290835 Global Action Plan on Antibiotic Resistance. . Available online Assessing Non-Prescription and Inappropriate Use of Antibiotics Report on Survey Available online Infection Prevention and Control. . Available online Implementation of Antibiotic Stewardship Core Elements at Small and Critical Access Hospitals. . Available online · DOI
  39. Pinto Ferreira, J., Battaglia, D., Dorado García, A., Tempelman, K., Bullon, C., Motriuc, N., Caudell, M., (...), LeJeune, J. (Open Access) (2022) Microorganisms, 10 (8), art. no. 1599. . doi: 10.3390/microorganisms10081599 · DOI
  40. Aidara-Kane, A., Angulo, F.J., Conly, J., Minato, Y., Silbergeld, E.K., McEwen, S.A., Collignon, P.J., (...), Wallinga, D. (Open Access) (2018) Antimicrobial Resistance and Infection Control, 7 (1), art. no. 7. . doi: 10.1186/s13756-017-0294-9 · DOI
  41. Mitchell, J., Cooke, P., Ahorlu, C., Arjyal, A., Baral, S., Carter, L., Dasgupta, R., (...), King, R. (Open Access) (2022) Global Public Health, 17 (11), pp. 2647-2664. . doi: 10.1080/17441692.2021.2003839 · DOI · Paper page
  42. Othman, L., Sleiman, A., Abdel-Massih, R.M. (Open Access) (2019) Frontiers in Microbiology, 10 (MAY), art. no. 911. . doi: 10.3389/fmicb.2019.00911 · DOI
  43. email: © Copyright 2023 Elsevier

Cited by

Sorted by citations

Authors
Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A.
Affiliations
  • International Islamic University Malaysia (MY)
  • Purdue University West Lafayette (US)
  • University of Rajshahi (BD)
  • Henry Ford Health (US)
  • Alfaisal University (SA)
  • Al Baha University (SA)
Corresponding author
Salam, Md. Abdus
Venue
Healthcare
Publisher
MDPI AG
Published
2023-05-09
Volume
11
Issue
13
Pages
1946-1946
ISSN
2227-9032 (ISSN-L)
OpenAlex
W4383273076
Cited by
2,411
References
0
Citations by year
2026: 817 · 2025: 1052 · 2024: 504 · 2023: 37
FWCI
45.86
Type
journal article
Language
en
Open access
Locations
  • Healthcare (publishedVersion, cc-by)
  • Preprints.org (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • The International Islamic University Malaysia Repository (The International Islamic University Malaysia) (submittedVersion, other-oa)
Funders
International Islamic University Malaysia
Topics
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
  • Physical Sciences › Environmental Science › Pollution › Pharmaceutical and Antibiotic Environmental Impacts
Keywords
antimicrobial resistance, antibiotic misuse, antimicrobial use in livestock, antibiotic resistance mechanisms, transmission of resistant bacteria, post-antibiotic era, antimicrobial resistance surveillance, veterinary antibiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review